Literature DB >> 26941832

Non-typhoidal Salmonella DNA traces in gallbladder cancer.

Prajish Iyer1, Savio George Barreto2, Bikram Sahoo1, Pratik Chandrani1, Mukta R Ramadwar3, Shailesh V Shrikhande4, Amit Dutt1.   

Abstract

BACKGROUND: We earlier proposed a genetic model for gallbladder carcinogenesis and its dissemination cascade. However, the association of gallbladder cancer and 'inflammatory stimulus' to drive the initial cascade in the model remained unclear. A recent study suggested infection with Salmonella can lead to changes in the host signalling pathways in gallbladder cancer.
FINDINGS: We examined the whole exomes of 26 primary gall bladder tumour and paired normal samples for presence of 143 HPV (Human papilloma virus) types along with 6 common Salmonella serotypes (S. typhi Ty2, S. typhi CT18, S. typhimurium LT2, S. choleraesuis SCB67, S. paratyphi TCC, and S. paratyphi SPB7) using a computational subtraction pipeline based on the HPVDetector, we recently described. Based on our evaluation of 26 whole exome gallbladder primary tumours and matched normal samples: association of typhoidal Salmonella species were found in 11 of 26 gallbladder cancer samples, and non-typhoidal Salmonella species in 12 of 26 gallbladder cancer, with 6 samples were found co-infected with both.
CONCLUSIONS: We present the first evidence to support the association of non-typhoidal Salmonella species along with typhoidal strains in gallbladder cancer. Salmonella infection in the chronic carrier state fits the role of the 'inflammatory stimulus' in the genetic model for gallbladder carcinogenesis that may play a role in gallbladder cancer analogous to Helicobacter pylori in gastric cancer.

Entities:  

Keywords:  Gall bladder cancer; Inflammation; Non-typhoidal; Salmonella

Year:  2016        PMID: 26941832      PMCID: PMC4776363          DOI: 10.1186/s13027-016-0057-x

Source DB:  PubMed          Journal:  Infect Agent Cancer        ISSN: 1750-9378            Impact factor:   2.965


Background

Gallbladder cancer with its attendant poor prognosis [1], despite the performance of good surgery when feasible [2], lends itself to the need for further research. Scanu et al. recently provided a novel mechanism by which chronic Salmonella infection of the gallbladder can lead to changes in the host signalling pathways triggering cellular transformations resembling the evolution of gallbladder cancer [3]. This is consistent with earlier epidemiological findings that support the association of typhoidal Salmonella typhi and S. paratyphi with the risk of gallbladder cancer [4-7]. However, non typhoidal species (S. typhimurium, S choleraesuis) that elicits a stronger host immune response compared to the typhoidal species and are linked to a systemic illness have as yet not reported to be associated with gallbladder disease or cancer [8]. Interestingly, in the Indian subcontinent where gallbladder incidence rates are amongst the highest in the world, Salmonella infection is also considerably severe [9]. We have previously proposed a model for gallbladder carcinogenesis based on the current understanding of the tumour biology and associated inflammation [10]. However, there remain lacunae in the model that need to be clarified. For instance, what is the ‘inflammatory stimulus’ that drives the initial cascade of an upregulation of inflammatory markers that is characterised by an increase in protective mucins as well as a strange divergence of inflammatory markers thereafter from the stage of in situ to invasive cancer? Here in this study we examined the exomes of primary gall bladder tumour and paired normal samples for presence of 6 common Salmonella serotypes with available genome information (S. typhi Ty2, S. typhi CT18, S. typhimurium LT2, S. choleraesuis SCB67, S. paratyphi TCC, and S. paratyphi SPB7) using a computational subtraction pipeline based on the HPVDetector tool [11]

Methods

Patient sample collection

Twenty six fresh frozen primary tumour and matched normal tissues were obtained from the tissue repository of Tata Memorial hospital (TMH). The Institutional Review Board (IRB) and the Ethics Committee (EC) of Tata Memorial Centre (TMC) - Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) (Mumbai, India) approved the project (#104). Since this was a retrospective analysis, the IRB and the EC waived the need for an informed consent. Patients were randomly selected based on the availability of fresh frozen tissues. The patient characteristics including age, gender, gall stone status and histopathology were recorded.

PCR analysis for Salmonella isolates

The PCR method used for Salmonella detection has been previously described [12]. Nested PCR was carried out in a 25 μl volume containing 10 μl KAPA 2X ready mix master-mix (KapaBiosystems catalog no-KK1024), 10 pmol primer and 100 ng of genomic DNA. Following the first round of PCR (94 °C for 1 min, 55 °C for 1 min 15 s, 72 °C for 3 min – 40 cycles) with ST1 and ST2 primers, 5 μl PCR product was used as template for nested PCR using ST3 and ST4 primers (94 °C for 1 min, 68 °C for 1 min 15 s, 72 °C for 3 min – 40 cycles). We also performed validation of Salmonella sequences using read specific primers. The PCR conditions - 94 °C for 1 min, 59 °C for 30s, 72 °C for 45 s – for 30 cycles. The primer sequences are detailed in Additional file 1: Table S2.

Sequencing and analysis

Exome capture and library preparation was performed using Agilent Sure select in-solution (low-input capture-500 ng) target enrichment technology. Genomic DNA was sheared and size selected (150–200 bp) and ligated to adaptors and run on Illumina Nextseq 500 platform to generate 150 bp paired end reads at a coverage of 100X and above. To detect Salmonella traces, the HPVDetector pipeline was used, as described previously [11]. Briefly, reads were aligned against six known Salmonella species genomes in addition of the HPVDetector nce data set of 143 HPV types, as downloaded from the National Centre for Biotechnology Information (NCBI), using BWA (Burrows wheeler algorithm) aligner (v0.6.2). All reference sequences were annotated and concatenated to compose a multi-fasta sequences using bio-perl modules. The alignment files were parsed using UNIX shell program to detect the types of Salmonella represented by at least one read that aligned to a particular Salmonella type with high confidence.

Results

HPVDetector pipeline identifies Salmonella sequence present in gallbladder cancer samples

We performed PCR based analysis of 26 gallbladder tumour and paired normal samples to detect the presence of Salmonella DNA using pan primers, as described earlier [12]. None of the gallbladder samples were found to be positive for Salmonella (data not shown). As a next step, whole exome data for these 26 samples (generated in house, manuscript in make) were analysed to detect Salmonella traces using HPVDetector pipeline, modified to include additional genome sequence of 6 common Salmonella isolates. The computational approach, in brief, subtracts all reads that align to human genome and aligns remaining reads to HPV and Salmonella reference database from NCBI. While HPV16 was detected in 1 gallbladder sample, Salmonella isolates were found across multiple samples: S. typhi Ty2 (3 samples), S. typhi CT18 (6 samples), S. typhimurium LT2 (10 samples), S. choleraesuis SCB67 (5 samples), S. paratyphi TCC (3 samples), and S. paratyphi SPB7 (7 samples). In total, Salmonella reads were found in 19 of 26 gallbladder tissues (tumor as well as adjacent normal tissues). Interestingly, 10 of 19 samples were co-infected with multiple isolates independent of gallstone status or gender of the patients, as shown in Fig. 1.
Fig. 1

Profiling the occurrence of 143 HPV types and 6 Salmonella isolates across 26 gall bladder cancer patients. Heat map representation of 6 Salmonella isolates (in row) found across 26 gallbladder samples -- 17 tumours and 9 matched normal (in column) is shown. Solid boxes indicate presence of reads from Salmonella genome in the corresponding gallbladder sample. The samples (column) have been grouped based on gender as shown above the heat map. Solid boxes in the first row indicate presence of HPV16 sequence. Solid boxes in the second row indicate the presence of mutation in TP53. Reads of HPV16 were found in 1 of 26 samples (10 T). 9 of 17 gallbladder tumour samples were associated with gall stones as shown by solid boxes in the second row. Typhoidal Salmonella isolates were found in 11 of 26 gallbladder cancer samples, non-typhoidal Salmonella isolates were found in 12 of 26 gallbladder cancer, with 6 of 26 samples co-infected with both

Profiling the occurrence of 143 HPV types and 6 Salmonella isolates across 26 gall bladder cancer patients. Heat map representation of 6 Salmonella isolates (in row) found across 26 gallbladder samples -- 17 tumours and 9 matched normal (in column) is shown. Solid boxes indicate presence of reads from Salmonella genome in the corresponding gallbladder sample. The samples (column) have been grouped based on gender as shown above the heat map. Solid boxes in the first row indicate presence of HPV16 sequence. Solid boxes in the second row indicate the presence of mutation in TP53. Reads of HPV16 were found in 1 of 26 samples (10 T). 9 of 17 gallbladder tumour samples were associated with gall stones as shown by solid boxes in the second row. Typhoidal Salmonella isolates were found in 11 of 26 gallbladder cancer samples, non-typhoidal Salmonella isolates were found in 12 of 26 gallbladder cancer, with 6 of 26 samples co-infected with both

Annotation of the Salmonella reads found in gallbladder cancer samples

Variable number of overlapping reads of variant lengths for each isolate were assembled into contigs based on Clustal X2 multiple alignment as shown in Additional file 2: Figure S1. The unique stretch of contigs generated were annotated based on gene annotation database of Salmonella isolates from NCBI (National centre for biotechnology information) database. 114 reads of multiple Salmonella isolates were found in 19 of 26 samples analyzed. 47 of 114 reads of Salmonella ORF (open reading frame) were identified as encoding for bacterium genes known to be involved in metabolism and those related to the toxin-antitoxin system. Rest of the reads aligned to the Salmonella ribosomal genes, understandably due to their relatively higher abundance (Additional file 3: Table S1).

HPVDetector pipeline is specific and highly sensitive to detect true Salmonella traces

To assess specificity of our assay, we re-analyzed whole exome data of all samples by taking their reverse (not complement) to simulate random sequence, but retaining composition of nucleotides and genome complexity, using an in-house perl script, as described earlier [11]. We found no spurious Salmonella reads when the primary tumour whole exome sequence was reversed in any of the 26 samples, suggesting the computational pipeline used was specific to detect Salmonella traces. (Additional file 4: Figure S2A). To test the sensitivity of our assay, raw FASTQ file of a primary tumour sample 16 T that was found positive for Salmonella reads was down-sampled to 1X, 5X, 10X, 15X, 25X, 50X, 75X and 100X coverage using Picard Toolkit’s DownsampleSam function (http://broadinstitute.github.io/picard/), as described earlier [11]. The resulting FASTQ files were analysed for detection of Salmonella reads using the HPVDetector pipeline. Distinct Salmonella reads were detected at as low as 10X whole exome coverage that increased linearly (Additional file 4: Figure S2B).

Sanger validation of Salmonella reads identified in gallbladder cancer samples

We have attempted to validate the presence of Salmonella read sequences identified by HPVDetector in 4 of 16 Salmonella positive samples using Sanger sequencing (Additional file 5: Figure S3).

Discussion

We examined Salmonella and HPV DNA sequences in gallbladder tumours and paired normals, The high incidence of Salmonella sequence found in 16 of 26 samples analysed in the study suggests a possible role of Salmonella infection in gallbladder cancer analogous to Helicobacter pylori in gastric cancer and Fusobacterium in colon cancer [13, 14]. We demonstrate the presence of typhoidal Salmonella species in 11 of 26 gallbladder cancer samples, consistent with as known earlier. In addition, we present the first evidence to support the association of even non-typhoidal Salmonella species in 12 of 26 gallbladder cancer, with 6 of 26 samples co-infected with typhoidal as well as non typhoidal Salmonella isolates. Systemic inflammation is known to be associated with a poor prognosis in gallbladder cancer [15]. Owing to the ability of Salmonella infection to stimulate a host response, it is likely that these bacteria are able to provide the continued ‘inflammatory stimulus’ necessary for carcinogenesis. Recent reports suggest that Salmonella infections promote malignant transformation in genetically predisposed mice, murine gall bladder organoids and fibroblasts with TP53 mutations [3]. We observed 4 of 16 Salmonella positive samples harboured TP53 mutations while we did not observe TP53 mutations in Salmonella negative samples. Salmonella isolates in the chronic carrier state thus fits the role of the ‘inflammatory stimulus’ in the genetic model for gallbladder carcinogenesis and its dissemination cascade, which may trigger transformation through chronic inflammation, but not for maintenance of tumourigenesis [10]. The focus of treatment in typhoid-endemic countries such as India has historically been solely on eliminating typhoidal Salmonella species often underestimating the contribution of the non-typhoidal isolates that show an inherent higher resistance to the standard antibiotics [8] resulting in their ability to lead to chronic carrier state in humans. The presence of non-typhoidal Salmonella species in our study highlights that in typhoid-, as well as gallbladder cancer-endemic countries such as India and other similar countries, efforts must be directed not only at treating typhoid fever, but also diagnosing and appropriately managing non-typhoidal Salmonella species. This simple approach could reduce the chronic carrier state of these species in humans, which by our hypothesis may be contributing to the inflammatory stimulus driving gallbladder carcinogenesis. Thus, this simple strategy may help reduce in the incidence of gallbladder cancer. While this study validates and extends the association of Salmonella with gall bladder carcinoma, further study is required to establish the causality of infection to the disease.
  15 in total

1.  Molecular Epidemiology of Nontyphoidal Salmonella in Poultry and Poultry Products in India: Implications for Human Health.

Authors:  Sellappan Saravanan; Venketaraman Purushothaman; Thippichettypalayam Ramasamy Gopala Krishna Murthy; Kuppannan Sukumar; Palani Srinivasan; Vasudevan Gowthaman; Mohan Balusamy; Robert Atterbury; Suresh V Kuchipudi
Journal:  Indian J Microbiol       Date:  2015-04-19       Impact factor: 2.461

Review 2.  Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer.

Authors:  V Nagaraja; G D Eslick
Journal:  Aliment Pharmacol Ther       Date:  2014-02-20       Impact factor: 8.171

3.  Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder.

Authors:  U Dutta; P K Garg; R Kumar; R K Tandon
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

Review 4.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

5.  Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction.

Authors:  J H Song; H Cho; M Y Park; D S Na; H B Moon; C H Pai
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.

Authors:  Xiang-Song Wu; Liu-Bin Shi; Mao-Lan Li; Qian Ding; Hao Weng; Wen-Guang Wu; Yang Cao; Run-Fa Bao; Yi-Jun Shu; Qi-Chen Ding; Jia-Sheng Mu; Jun Gu; Ping Dong; Ying-Bin Liu
Journal:  Ann Surg Oncol       Date:  2013-10-01       Impact factor: 5.344

7.  Cancer mortality in chronic typhoid and paratyphoid carriers.

Authors:  C P Caygill; M J Hill; M Braddick; J C Sharp
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

8.  NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome.

Authors:  P Chandrani; V Kulkarni; P Iyer; P Upadhyay; R Chaubal; P Das; R Mulherkar; R Singh; A Dutt
Journal:  Br J Cancer       Date:  2015-05-14       Impact factor: 7.640

Review 9.  Gallbladder cancer: epidemiology and outcome.

Authors:  Rajveer Hundal; Eldon A Shaffer
Journal:  Clin Epidemiol       Date:  2014-03-07       Impact factor: 4.790

Review 10.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

View more
  15 in total

1.  Roles of Salmonella typhi and Salmonella paratyphi in Gallbladder Cancer Development.

Authors:  Ratnakar Shukla; Pooja Shukla; Anu Behari; Dheeraj Khetan; Rajendra K Chaudhary; Yasuo Tsuchiya; Toshikazu Ikoma; Takao Asai; Kazutoshi Nakamura; Vinay K Kapoor
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

Review 2.  Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

Authors:  Aarti Sharma; Kiran Lata Sharma; Annapurna Gupta; Alka Yadav; Ashok Kumar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

Review 3.  Salmonella Infection in Chronic Inflammation and Gastrointestinal Cancer.

Authors:  Lang Zha; Shari Garrett; Jun Sun
Journal:  Diseases       Date:  2019-03-10

4.  Subclinical Lipopolysaccharide from Salmonella Enteritidis Induces Dysregulation of Bioactive Substances from Selected Brain Sections and Glands of Neuroendocrine Axes.

Authors:  Anita Mikołajczyk; Dagmara Złotkowska
Journal:  Toxins (Basel)       Date:  2019-02-02       Impact factor: 4.546

5.  miR‑146b‑5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll‑like receptor 4 via the nuclear factor‑κB pathway.

Authors:  Bin Ouyang; Ningfeng Pan; Haifeng Zhang; Chuanming Xing; Wu Ji
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

6.  To improve outcomes of gallbladder cancer we need to better understand it!

Authors:  Savio G Barreto; Amit Dutt
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

Review 7.  The Four Horsemen in Colon Cancer.

Authors:  Marco Antonio Hernández-Luna; Sergio López-Briones; Rosendo Luria-Pérez
Journal:  J Oncol       Date:  2019-09-29       Impact factor: 4.375

8.  ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.

Authors:  Prajish Iyer; Shailesh V Shrikhande; Malika Ranjan; Asim Joshi; Nilesh Gardi; Ratnam Prasad; Bhasker Dharavath; Rahul Thorat; Sameer Salunkhe; Bikram Sahoo; Pratik Chandrani; Hitesh Kore; Bhabani Mohanty; Vikram Chaudhari; Anuradha Choughule; Dhananjay Kawle; Pradip Chaudhari; Arvind Ingle; Shripad Banavali; Poonam Gera; Mukta R Ramadwar; Kumar Prabhash; Savio George Barreto; Shilpee Dutt; Amit Dutt
Journal:  Int J Cancer       Date:  2018-12-08       Impact factor: 7.396

9.  Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.

Authors:  Vívian D'Afonseca; Ariel D Arencibia; Alex Echeverría-Vega; Leslie Cerpa; Juan P Cayún; Nelson M Varela; Marcela Salazar; Luis A Quiñones
Journal:  Cancer Inform       Date:  2020-05-25

10.  Survival analysis of patients with primary gallbladder cancer from 2010 to 2015: A retrospective study based on SEER data.

Authors:  Xiaolei Zhu; Xiaochang Zhang; Xiao Hu; Hongyan Ren; Shenghui Wu; Jing Wu; Guoyi Wu; Xiang Si; Baohua Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.